showed a trendp = 0.052
The application of full-dose cisplatin chemotherapy (≥ 200 mg per square meter body surface total dose) was significantly associated only with OS, and showed a trend towards significance for RFS ( p = 0.052, Table 3 ).
The application of full-dose cisplatin chemotherapy (≥ 200 mg per square meter body surface total dose) was significantly associated only with OS, and showed a trend towards significance for RFS ( p = 0.052, Table 3 ).
The NLR remained a significant prognostic factor when used for each volume group separately: Patients with elevated NLR (> = 4.68) showed a significantly reduced recurrence-free survival in all tumor volume groups (15 cm 3 , 15-70 cm 3 , >70 cm 3 ) as well as a significantly inferior overall survival in the high-tumor volume group and a trend towards significance for the intermediate volume group (Fig. 3 ).